LFMD Q3 2024 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q3 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$53M+38.0% YoY

Gross Profit

$48M90.6% margin

Operating Income

-$4M-7.5% margin

Net Income

-$5M-8.7% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$73M

Total Liabilities

$79M

Stockholders' Equity

-$8M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$39M	+38.0%
Gross Profit	$48M	$34M	+42.6%
Operating Income	-$4M	-$5M	+12.5%
Net Income	-$5M	-$6M	+23.9%